Trial Profile
A multi-center, randomized, open-label study to evaluate efficacy and safety of dual therapy with atorvastatin plus amlodipine when compared amlodopine therapy alone in the treatment of subjects with concurrent hyperlipidemia and hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/atorvastatin (Primary) ; Amlodipine
- Indications Hyperlipidaemia; Hypertension
- Focus Therapeutic Use
- Sponsors Viatris Inc
- 29 Aug 2006 Status change
- 14 Nov 2005 New trial record.